Differences in tachyarrhythmia detection and implantable cardioverter defibrillator therapy by primary or secondary prevention indication in cardiac resynchronization therapy patients

Journal of Cardiovascular Electrophysiology

Volumn 15, Issue 9, 2004, Pages 1002-1009

  Wilkoff, Bruce L ^a   Hess, Mike ^b   Young, James ^a   Abraham, William T ^c  

^a LERNER RESEARCH INSTITUTE   (United States)

^b MEDTRONIC INC   (United States)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

Cardiac resynchronization therapy; Defibrillation; Heart failure; Primary prevention; Tachyarrhythmias

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; INOTROPIC AGENT;

CLINICAL TRIAL; CONVULSIVE THERAPY; DEFIBRILLATION; DEFIBRILLATOR; DEMOGRAPHY; DIZZINESS; ELECTROSTIMULATION; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART CYCLE; HEART FAILURE; HEART LEFT VENTRICLE FAILURE; HEART RESYNCHRONIZATION THERAPY; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; IMPLANTATION; PRIMARY PREVENTION; PRIORITY JOURNAL; REVIEW; SECONDARY PREVENTION; SINUS TACHYCARDIA; SYNCOPE; THERAPY;

AGED; CARDIAC PACING, ARTIFICIAL; DEFIBRILLATORS, IMPLANTABLE; DOUBLE-BLIND METHOD; ELECTRIC COUNTERSHOCK; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; FEMALE; HUMANS; MALE; MIDDLE AGED; PRIMARY PREVENTION; RETROSPECTIVE STUDIES; TACHYCARDIA, VENTRICULAR; VENTRICULAR FIBRILLATION;

EID: 4644371055     PISSN: 10453873     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1540-8167.2004.03625.x     Document Type: Review

References (20)

1. AVID Investigators: A comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997;337:1576-1583.
2. Kuck K, Cappato R, Siebels J, Rüppel R, for the CASH Investigators: Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest. The Cardiac Arrest Study Hamburg (CASH). Circulation 2000;102:748-754.
3. Connolly S, Gent M, Roberts R, Dorian P, Roy D, Shelton R, Mitchel L, Green M, Klein G, O'Brien B, for the CIDS Investigators: Canadian Implantable Defibrillator Study (CIDS). Circulation 2000;101:1297-1302.
4. Moss A, Hall W, Cannom D, Daubert J, Higgins S, Klein H, Levine J, Saksena S, Waldo A, Wilber D, Brown M, Heo M, for the MADIT Trial Investigators: Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 1996;335:1933-1940.
5. Buxton A, Lee K, Fisher J, Josephson M, Prystowsky E, Hafley G, for the MUSTT Investigators: A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med 1999;341:1882-1890.
6. Moss A, Zareba W, Hall W, Klein H, Wilber D, Cannom D, Daubert J, Higgins S, Brown M, Andrews M, for the MADIT II Investigators: Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-883.
7. Farwell D, Patel NR, Hall A, Ralph S, Sulke AN. How many people with heart failure are appropriate for biventricular resynchronization? Eur Heart J 2000;21:1246-1250.
8. Young J, Abraham W, Smith A, Leon A, Lieberman R, Wilkoff B, Canby R, Schroeder J, Liem L, Hall S, Wheelan K, for the MIRACLE ICD Trial Investigators: Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure. The MIRACLE ICD Trial. JAMA 2003;289:2685-2694.
9. Wilkoff B, Kuhlkamp G, Volosin K, Ellenbogen K, Waldecker B, Kacet S, Gillberg J, DeSouza C: Critical analysis of dual chamber cardioverter- defibrillator arrhythmia detection. Circulation 2001;103:383-386.
10. Bradley D, Bradley E, Baughman K: Cardiac resynchronization and death from progressive heart failure: a meta-analysis of randomized controlled trials. JAMA 2003;289:730-740.
11. Abraham W, Fisher W, Smith A, Delurgio D, Leon A, Loh E, Kocovic D, Packer M, Clavell A, Hayes D, Ellestad M, Messenger J, for the MIRACLE study group: Cardiac resynchronization in chronic heart failure. N Engl J Med 2002;346:1845-1853.
12. Cazeau S, Leclercq C., Lavergne T, Walker S, Varma C, Linde C, Garrigue S, Kappenberger L, Haywood G, Santini M, Bailleul C, Daubert J: Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 2001;344:873-880.
13. Klein R, Raitt M, Wilkoff B, Beckman K, Coromilas J, Wyse G, Friedman P, Martins J, Epstein A, Hallstrom A, Ledingham R, Belco K, Greene L, and the AVID Investigators: Analysis of implantable cardioverter-defibrillator therapy in the antiarrhythmics versus implantable defibrillator (avid) trial. J Cardiovasc Electrophysiol 2003;14:940-948.
14. Daubert J, Zareba W, Cannom D, Schuger C, Wang P, Andrews M, Hall J, Moss A: Frequency and mechanisms of inappropriate implantable cardioverter defibrillator therapy in MADIT II. (Abstract) J Am Coll Cardiol 2004;43:132A.
15. Bloomfield D, Block M: Stored electrogram analysis of shocks in the CABG Patch trial: A potential explanation for the limited survival benefit of defibrillators. (Abstract) Pacing Clin Electrophysiol 1998;21: 818.
16. McCready M, Exner D: Quality of life and psychological impact of implantable cardioverter defibrillators: Focus on randomized controlled trial data. Card Electrophysiol Rev 2003;7:63-70.
17. Namerow P, Firth B, Heywood G, Windle J, Parides M: Quality-of-life six months after CABG surgery in patients randomized to ICD versus no ICD therapy: Findings from the CABG Patch trial. Pacing Clin Electrophysiol 1999;22:1305-1313.
18. Wathen M, Sweeney M, DeGroot P, Stark A, Koehler J, Chisner M, Machado C, Adkisson W: Shock reduction using antitachycardia pacing for spontaneous rapid ventricular tachycardia in patients with coronary artery disease. Circulation 2001;104:796-801.
19. Raitt M, Dolack G, Kudenchuk P, Poole J, Bardy G: Electrophysiology/ arrhythmias: Ventricular arrhythmias detected after transvenous defibrillator implantation in patients with a clinical history of only ventricular fibrillation: Implications for use of implantable defibrillator. Circulation 1995;91:1996-2001.
20. Russo A, Nayak H, Verdino R, Springman J, Gerstenfeld E, Hsia H, Marchlinski F: Implantable cardioverter defibrillator events in patients with asymptomatic nonsustained ventricular tachycardia: Is device implantation justified? Pacing Clin Electrophysiol 2003;26:2289-2295.